Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Schedule of Stock Options Activity (Details)

v3.24.1
Stockholders' Equity - Schedule of Stock Options Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Number of Shares      
Number of shares, outstanding, beginning (in shares) 3,952,000 5,110,000  
Number of shares options granted (in shares) 1,135,000 1,095,000  
Number of shares options exercised (in shares) (1,348,000) (1,833,000)  
Number of shares options forfeited (in shares) (788,000) (420,000)  
Number of shares, outstanding, ending (in shares) 2,951,000 3,952,000 5,110,000
Number of shares, options vested and exercisable (in shares) 1,880,000    
Weighted Average Exercise Price      
Weighted average exercise price, outstanding, beginning (in dollars per share) $ 5.35 $ 3.27  
Weighted average exercise price, granted (in dollars per share) 8.65 9.92  
Weighted average exercise price, exercised (in dollars per share) 0.98 1.29  
Weighted average exercise price, forfeited (in dollars per share) 0.64 1.56  
Weighted average exercise price, outstanding, ending (in dollars per share) 7.30 $ 5.35 $ 3.27
Weighted average exercise price, options vested and exercisable (in dollars per share) $ 6.69    
Weighted Average Remaining Contractual Life (in years) and Total Intrinsic Value      
Weighted average remaining contractual life, outstanding shares (in years) 4 years 9 months 18 days 3 years 9 months 18 days 3 years 4 months 24 days
Weighted average remaining contractual life, granted shares (in years) 5 years 7 years  
Weighted average remaining contractual life, options vested and exercisable (in years) 4 years 1 month 6 days    
Total intrinsic value, outstanding, beginning $ 20,379 $ 20,820  
Total intrinsic value, outstanding, ending 693 $ 20,379 $ 20,820
Total intrinsic value, options vested and exercisable $ 693